NASDAQ: SGMTSagimet Biosciences Revenue
Sagimet Biosciences revenue was $0.00 for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SGMT annual revenue was $0.0, with -100% growth year-over-year.
SGMT past revenue growth
How has SGMT's revenue growth performed historically?
Company
N/A
Industry
270.78%
Market
22.17%
SGMT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SGMT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SGMT revenue history
Current Revenue
$0.0
Current Earnings
-$57.7M
Current Profit Margin
0%
Be the first to know when SGMT announces revenue.
SGMT Revenue History By Year
| SGMT Yearly Revenue | SGMT Revenue | SGMT Change | SGMT Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $0.00 | -$2.00M | -100.00% |
| 2023-12-31 | $2.00M | N/A | N/A |
| 2022-12-31 | $0.00 | N/A | N/A |
| 2021-12-31 | $0.00 | N/A | N/A |
Sagimet Biosciences Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.